There is a growing body of evidence to support the use of medical cannabis as an adjunct to or substitute for prescription opiates in the treatment of chronic pain. When used in conjunction with opiates, cannabinoids lead to a greater cumulative relief of pain, resulting in a reduction in the use of opiates (and associated side-effects) by patients in a clinical setting. Additionally, cannabinoids can prevent the development of tolerance to and withdrawal from opiates, and can even rekindle opiate analgesia after a prior dosage has become ineffective.
A compound found in marijuana can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Unlike the main ingredient in marijuana, THC, which can produce psychotic reactions and may worsen schizophrenia, cannabidiol (CBD) has antipsychotic effects, according to previous research in both animals and humans.
Half a century ago, Hebrew University Prof. Raphael Mechoulam isolated and synthesized THC, the main psychoactive compound in the cannabis plant. By 1963, Mechoulam and his research partners had revealed the structure of cannabidiol (CBD), a key ingredient in cannabis. By the following year they had isolated THC for the first time, established its structure and synthesized it.
The legal status of cannabis for personal use is one of the most controversial policy issues in the European Union. Although cannabis is a classified narcotic drug placed under control by the United Nations and by all EU Member States, the measures adopted to control it at national level vary considerably, as shown in the table, click here to access the information country by country.
Marijuana has been shown to have both anxiolytic (anti-anxiety) effects and to induce anxiety and psychosis in certain people. In schizophrenics, it can increase symptoms, and in healthy people it can increase the risk of schizophrenia. Now, new study shows that the two active ingredients in pot, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) may have quite opposite effects on the brain – and behavior – and could explain why pot’s effects can be unpredictable.
New research finds that the two main ingredients in marijuana have opposing effects on it. The study examined 15 normal men who had previously smoked cannabis only a few times. Researchers exposed the men to each of the two most psychoactive ingredients in marijuana — delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) and compared their effects with those of a placebo while the participants performed a mental task.